Summary
This paper discusses the potential for eNpHR-based gene therapy to restore complex visual responses in Retinitis pigmentosa, a degenerative eye disease, and the criteria for selecting patients for this therapy.
Categories
Eye health: The paper discusses the potential for eNpHR-based gene therapy to restore complex visual responses in Retinitis pigmentosa, a degenerative eye disease.
Genetic Disorders: The paper discusses the potential for gene therapy to treat Retinitis pigmentosa, a genetic disorder that causes degeneration of the eye.
Author(s)
V Busskamp, J Duebel, D Balya, M Fradot, TJ Viney
Publication Year
2010
Number of Citations
732
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
Genetic Disorders
- Drug discovery strategies for inherited retinal degenerations
- Molecular genetics of ocular diseases
- The causes of retinal dystrophy and the development of more comprehensive screening approach
- LncRNA-XR_002792574. 1-mediated ceRNA network reveals potential biomarkers in myopia-induced retinal ganglion cell damage
- Roles of PIKfyve in the Retina: A Zebrafish Study